Chemed Corporation Logo

Chemed Corporation

CHE

(3.0)
Stock Price

557,95 USD

30.84% ROA

26.64% ROE

29.47x PER

Market Cap.

8.840.278.239,00 USD

12.13% DER

0.29% Yield

12.88% NPM

Chemed Corporation Stock Analysis

Chemed Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Chemed Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (26.8%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a minimal amount of debt (13%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Dividend Growth

With a history of consistent dividend increases over the last five years, the company has proven to be a reliable choice for investors seeking steady income.

5 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

6 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (5.921), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 PBV

The stock's high Price-to-Book Value (P/BV) ratio (8.61x) suggests it's overvalued, potentially making it an expensive investment.

9 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

11 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

Chemed Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Chemed Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Chemed Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Chemed Corporation Revenue
Year Revenue Growth
1985 372.700.000
1986 359.500.000 -3.67%
1987 391.000.000 8.06%
1988 500.600.000 21.89%
1989 591.800.000 15.41%
1990 599.400.000 1.27%
1991 352.300.000 -70.14%
1992 401.000.000 12.14%
1993 525.100.000 23.63%
1994 645.000.000 18.59%
1995 699.200.000 7.75%
1996 683.800.000 -2.25%
1997 341.700.000 -100.12%
1998 381.300.000 10.39%
1999 453.600.000 15.94%
2000 500.685.000 9.4%
2001 477.116.000 -4.94%
2002 314.176.000 -51.86%
2003 308.871.000 -1.72%
2004 735.341.000 58%
2005 926.477.000 20.63%
2006 1.018.587.000 9.04%
2007 1.100.058.000 7.41%
2008 1.148.941.000 4.25%
2009 1.190.236.000 3.47%
2010 1.280.545.000 7.05%
2011 1.355.970.000 5.56%
2012 1.430.043.000 5.18%
2013 1.413.329.000 -1.18%
2014 1.456.282.000 2.95%
2015 1.543.388.000 5.64%
2016 1.576.881.000 2.12%
2017 1.666.724.000 5.39%
2018 1.782.648.000 6.5%
2019 1.938.555.000 8.04%
2020 2.079.583.000 6.78%
2021 2.139.261.000 2.79%
2022 2.134.963.000 -0.2%
2023 2.258.128.000 5.45%
2023 2.264.417.000 0.28%
2024 2.383.520.000 5%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Chemed Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Chemed Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 162.500.000
1986 159.100.000 -2.14%
1987 169.500.000 6.14%
1988 194.200.000 12.72%
1989 211.600.000 8.22%
1990 226.400.000 6.54%
1991 107.700.000 -110.21%
1992 117.000.000 7.95%
1993 143.900.000 18.69%
1994 177.600.000 18.98%
1995 190.600.000 6.82%
1996 197.200.000 3.35%
1997 100.900.000 -95.44%
1998 113.400.000 11.02%
1999 136.900.000 17.17%
2000 148.232.000 7.64%
2001 146.710.000 -1.04%
2002 95.512.000 -53.6%
2003 105.899.000 9.81%
2004 138.285.000 23.42%
2005 151.670.000 8.83%
2006 161.183.000 5.9%
2007 184.060.000 12.43%
2008 175.333.000 -4.98%
2009 197.426.000 11.19%
2010 201.964.000 2.25%
2011 202.260.000 0.15%
2012 208.656.000 3.07%
2013 212.518.000 1.82%
2014 220.118.000 3.45%
2015 237.821.000 7.44%
2016 243.572.000 2.36%
2017 276.652.000 11.96%
2018 270.209.000 -2.38%
2019 305.712.000 11.61%
2020 330.218.000 7.42%
2021 366.727.000 9.96%
2022 358.727.000 -2.23%
2023 381.380.000 5.94%
2023 395.120.000 3.48%
2024 398.472.000 0.84%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Chemed Corporation EBITDA
Year EBITDA Growth
1985 49.600.000
1986 64.000.000 22.5%
1987 56.000.000 -14.29%
1988 59.800.000 6.35%
1989 67.500.000 11.41%
1990 55.100.000 -22.5%
1991 2.200.000 -2404.55%
1992 9.900.000 77.78%
1993 20.300.000 51.23%
1994 35.300.000 42.49%
1995 34.700.000 -1.73%
1996 15.100.000 -129.8%
1997 15.800.000 4.43%
1998 18.600.000 15.05%
1999 35.900.000 48.19%
2000 50.399.000 28.77%
2001 66.395.000 24.09%
2002 50.287.000 -32.03%
2003 25.486.000 -97.31%
2004 91.700.000 72.21%
2005 127.847.000 28.27%
2006 126.282.000 -1.24%
2007 163.095.000 22.57%
2008 155.835.000 -4.66%
2009 154.247.000 -1.03%
2010 172.565.000 10.62%
2011 183.226.000 5.82%
2012 191.410.000 4.28%
2013 197.793.000 3.23%
2014 204.681.000 3.37%
2015 217.968.000 6.1%
2016 215.831.000 -0.99%
2017 157.521.000 -37.02%
2018 283.453.000 44.43%
2019 311.349.000 8.96%
2020 454.928.000 31.56%
2021 411.233.000 -10.63%
2022 393.435.000 -4.52%
2023 436.352.000 9.84%
2023 403.695.000 -8.09%
2024 415.352.000 2.81%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Chemed Corporation Gross Profit
Year Gross Profit Growth
1985 219.800.000
1986 212.100.000 -3.63%
1987 228.700.000 7.26%
1988 256.400.000 10.8%
1989 282.800.000 9.34%
1990 284.200.000 0.49%
1991 125.300.000 -126.82%
1992 141.400.000 11.39%
1993 180.200.000 21.53%
1994 222.400.000 18.97%
1995 241.800.000 8.02%
1996 247.300.000 2.22%
1997 135.700.000 -82.24%
1998 150.800.000 10.01%
1999 183.800.000 17.95%
2000 205.145.000 10.4%
2001 181.639.000 -12.94%
2002 127.891.000 -42.03%
2003 126.061.000 -1.45%
2004 228.263.000 44.77%
2005 274.636.000 16.89%
2006 288.464.000 4.79%
2007 332.992.000 13.37%
2008 338.394.000 1.6%
2009 355.662.000 4.86%
2010 374.529.000 5.04%
2011 385.486.000 2.84%
2012 396.722.000 2.83%
2013 404.521.000 1.93%
2014 421.609.000 4.05%
2015 455.778.000 7.5%
2016 461.450.000 1.23%
2017 516.192.000 10.6%
2018 554.004.000 6.83%
2019 617.429.000 10.27%
2020 701.386.000 11.97%
2021 769.803.000 8.89%
2022 765.086.000 -0.62%
2023 808.696.000 5.39%
2023 737.950.000 -9.59%
2024 761.668.000 3.11%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Chemed Corporation Net Profit
Year Net Profit Growth
1985 21.900.000
1986 36.800.000 40.49%
1987 20.400.000 -80.39%
1988 21.900.000 6.85%
1989 26.200.000 16.41%
1990 16.600.000 -57.83%
1991 52.900.000 68.62%
1992 15.700.000 -236.94%
1993 19.500.000 19.49%
1994 43.900.000 55.58%
1995 23.100.000 -90.04%
1996 32.300.000 28.48%
1997 30.300.000 -6.6%
1998 19.900.000 -52.26%
1999 19.700.000 -1.02%
2000 20.584.000 4.29%
2001 -10.375.000 298.4%
2002 -1.813.000 -472.26%
2003 -3.435.000 47.22%
2004 27.512.000 112.49%
2005 35.817.000 23.19%
2006 50.651.000 29.29%
2007 63.976.000 20.83%
2008 71.017.000 9.91%
2009 73.784.000 3.75%
2010 81.831.000 9.83%
2011 85.979.000 4.82%
2012 89.304.000 3.72%
2013 77.227.000 -15.64%
2014 99.317.000 22.24%
2015 110.274.000 9.94%
2016 108.743.000 -1.41%
2017 98.177.000 -10.76%
2018 205.544.000 52.24%
2019 219.923.000 6.54%
2020 319.466.000 31.16%
2021 268.550.000 -18.96%
2022 249.624.000 -7.58%
2023 299.832.000 16.75%
2023 272.509.000 -10.03%
2024 283.548.000 3.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Chemed Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 1
1986 2 50%
1987 1 -100%
1988 1 0%
1989 1 0%
1990 1 0%
1991 3 100%
1992 1 0%
1993 1 100%
1994 2 50%
1995 1 -100%
1996 2 0%
1997 2 0%
1998 1 0%
1999 1 0%
2000 1 100%
2001 -1 0%
2002 0 0%
2003 0 0%
2004 1 100%
2005 1 0%
2006 2 0%
2007 3 50%
2008 3 33.33%
2009 3 0%
2010 4 0%
2011 4 25%
2012 5 0%
2013 4 0%
2014 6 20%
2015 7 16.67%
2016 7 0%
2017 6 0%
2018 13 50%
2019 14 7.69%
2020 20 35%
2021 17 -17.65%
2022 17 -6.25%
2023 20 15.79%
2023 18 -5.56%
2024 19 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Chemed Corporation Free Cashflow
Year Free Cashflow Growth
1989 33.700.000
1990 27.000.000 -24.81%
1991 8.800.000 -206.82%
1992 9.900.000 11.11%
1993 3.800.000 -160.53%
1994 4.700.000 19.15%
1995 3.400.000 -38.24%
1996 16.800.000 79.76%
1997 13.300.000 -26.32%
1998 -16.000.000 183.13%
1999 -10.400.000 -53.85%
2000 20.835.000 149.92%
2001 20.228.000 -3%
2002 17.668.000 -14.49%
2003 11.412.000 -54.82%
2004 75.865.000 84.96%
2005 54.057.000 -40.34%
2006 76.602.000 29.43%
2007 72.944.000 -5.01%
2008 85.989.000 15.17%
2009 139.336.000 38.29%
2010 60.373.000 -130.79%
2011 144.751.000 58.29%
2012 96.516.000 -49.98%
2013 121.523.000 20.58%
2014 66.708.000 -82.17%
2015 127.365.000 47.62%
2016 95.621.000 -33.2%
2017 98.195.000 2.62%
2018 234.266.000 58.08%
2019 248.227.000 5.62%
2020 430.458.000 42.33%
2021 249.922.000 -72.24%
2022 252.561.000 1.04%
2023 273.445.000 7.64%
2023 17.272.000 -1483.17%
2024 66.455.000 74.01%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Chemed Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 47.800.000
1990 40.000.000 -19.5%
1991 20.200.000 -98.02%
1992 18.100.000 -11.6%
1993 17.700.000 -2.26%
1994 23.100.000 23.38%
1995 18.800.000 -22.87%
1996 35.800.000 47.49%
1997 33.400.000 -7.19%
1998 20.800.000 -60.58%
1999 27.500.000 24.36%
2000 51.838.000 46.95%
2001 34.362.000 -50.86%
2002 29.523.000 -16.39%
2003 22.590.000 -30.69%
2004 94.155.000 76.01%
2005 80.013.000 -17.67%
2006 98.589.000 18.84%
2007 99.584.000 1%
2008 112.083.000 11.15%
2009 160.832.000 30.31%
2010 86.012.000 -86.99%
2011 174.343.000 50.67%
2012 131.768.000 -32.31%
2013 150.847.000 12.65%
2014 110.279.000 -36.79%
2015 171.500.000 35.7%
2016 135.393.000 -26.67%
2017 162.495.000 16.68%
2018 287.138.000 43.41%
2019 301.249.000 4.68%
2020 489.289.000 38.43%
2021 308.597.000 -58.55%
2022 309.886.000 0.42%
2023 330.299.000 6.18%
2023 28.927.000 -1041.84%
2024 77.517.000 62.68%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Chemed Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 14.100.000
1990 13.000.000 -8.46%
1991 11.400.000 -14.04%
1992 8.200.000 -39.02%
1993 13.900.000 41.01%
1994 18.400.000 24.46%
1995 15.400.000 -19.48%
1996 19.000.000 18.95%
1997 20.100.000 5.47%
1998 36.800.000 45.38%
1999 37.900.000 2.9%
2000 31.003.000 -22.25%
2001 14.134.000 -119.35%
2002 11.855.000 -19.22%
2003 11.178.000 -6.06%
2004 18.290.000 38.88%
2005 25.956.000 29.53%
2006 21.987.000 -18.05%
2007 26.640.000 17.47%
2008 26.094.000 -2.09%
2009 21.496.000 -21.39%
2010 25.639.000 16.16%
2011 29.592.000 13.36%
2012 35.252.000 16.06%
2013 29.324.000 -20.22%
2014 43.571.000 32.7%
2015 44.135.000 1.28%
2016 39.772.000 -10.97%
2017 64.300.000 38.15%
2018 52.872.000 -21.61%
2019 53.022.000 0.28%
2020 58.831.000 9.87%
2021 58.675.000 -0.27%
2022 57.325.000 -2.35%
2023 56.854.000 -0.83%
2023 11.655.000 -387.81%
2024 11.062.000 -5.36%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Chemed Corporation Equity
Year Equity Growth
1985 90.500.000
1986 119.800.000 24.46%
1987 113.200.000 -5.83%
1988 111.200.000 -1.8%
1989 145.100.000 23.36%
1990 136.300.000 -6.46%
1991 165.400.000 17.59%
1992 162.200.000 -1.97%
1993 169.200.000 4.14%
1994 222.500.000 23.96%
1995 249.700.000 10.89%
1996 228.700.000 -9.18%
1997 228.100.000 -0.26%
1998 223.400.000 -2.1%
1999 212.000.000 -5.38%
2000 228.405.000 7.18%
2001 222.522.000 -2.64%
2002 203.277.000 -9.47%
2003 192.693.000 -5.49%
2004 332.092.000 41.98%
2005 384.175.000 13.56%
2006 421.361.000 8.83%
2007 364.349.000 -15.65%
2008 371.592.000 1.95%
2009 477.162.000 22.12%
2010 462.049.000 -3.27%
2011 413.684.000 -11.69%
2012 453.291.000 8.74%
2013 448.890.000 -0.98%
2014 451.356.000 0.55%
2015 513.253.000 12.06%
2016 524.099.000 2.07%
2017 540.354.000 3.01%
2018 591.334.000 8.62%
2019 726.608.000 18.62%
2020 901.200.000 19.37%
2021 623.273.000 -44.59%
2022 798.715.000 21.97%
2023 1.019.243.000 21.64%
2023 1.107.876.000 8%
2024 1.207.297.000 8.24%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Chemed Corporation Assets
Year Assets Growth
1985 229.900.000
1986 273.800.000 16.03%
1987 263.800.000 -3.79%
1988 322.700.000 18.25%
1989 335.300.000 3.76%
1990 327.500.000 -2.38%
1991 364.300.000 10.1%
1992 404.900.000 10.03%
1993 430.300.000 5.9%
1994 505.500.000 14.88%
1995 531.900.000 4.96%
1996 559.400.000 4.92%
1997 448.800.000 -24.64%
1998 429.700.000 -4.44%
1999 421.300.000 -1.99%
2000 421.375.000 0.02%
2001 396.511.000 -6.27%
2002 338.929.000 -16.99%
2003 329.069.000 -3%
2004 825.566.000 60.14%
2005 835.085.000 1.14%
2006 793.287.000 -5.27%
2007 772.313.000 -2.72%
2008 760.924.000 -1.5%
2009 819.470.000 7.14%
2010 830.161.000 1.29%
2011 795.905.000 -4.3%
2012 859.626.000 7.41%
2013 893.701.000 3.81%
2014 859.932.000 -3.93%
2015 852.325.000 -0.89%
2016 880.059.000 3.15%
2017 920.026.000 4.34%
2018 975.529.000 5.69%
2019 1.268.317.000 23.08%
2020 1.434.911.000 11.61%
2021 1.342.723.000 -6.87%
2022 1.442.012.000 6.89%
2023 1.562.079.000 7.69%
2023 1.760.787.000 11.29%
2024 1.734.984.000 -1.49%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Chemed Corporation Liabilities
Year Liabilities Growth
1985 139.400.000
1986 154.000.000 9.48%
1987 150.600.000 -2.26%
1988 211.500.000 28.79%
1989 190.200.000 -11.2%
1990 191.200.000 0.52%
1991 198.900.000 3.87%
1992 242.700.000 18.05%
1993 261.100.000 7.05%
1994 283.000.000 7.74%
1995 282.200.000 -0.28%
1996 330.700.000 14.67%
1997 220.700.000 -49.84%
1998 206.300.000 -6.98%
1999 209.300.000 1.43%
2000 192.970.000 -8.46%
2001 173.989.000 -10.91%
2002 135.652.000 -28.26%
2003 136.376.000 0.53%
2004 493.474.000 72.36%
2005 450.910.000 -9.44%
2006 371.926.000 -21.24%
2007 407.964.000 8.83%
2008 389.332.000 -4.79%
2009 342.308.000 -13.74%
2010 368.112.000 7.01%
2011 382.221.000 3.69%
2012 406.335.000 5.93%
2013 444.811.000 8.65%
2014 408.576.000 -8.87%
2015 339.072.000 -20.5%
2016 355.960.000 4.74%
2017 379.672.000 6.25%
2018 384.195.000 1.18%
2019 541.709.000 29.08%
2020 533.711.000 -1.5%
2021 719.450.000 25.82%
2022 643.297.000 -11.84%
2023 542.836.000 -18.51%
2023 652.911.000 16.86%
2024 527.687.000 -23.73%

Chemed Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
154.7
Net Income per Share
19.93
Price to Earning Ratio
29.47x
Price To Sales Ratio
3.79x
POCF Ratio
29.6
PFCF Ratio
34.96
Price to Book Ratio
7.35
EV to Sales
3.75
EV Over EBITDA
20.48
EV to Operating CashFlow
29.26
EV to FreeCashFlow
34.65
Earnings Yield
0.03
FreeCashFlow Yield
0.03
Market Cap
8,84 Bil.
Enterprise Value
8,76 Bil.
Graham Number
189.38
Graham NetNet
-10.64

Income Statement Metrics

Net Income per Share
19.93
Income Quality
1
ROE
0.27
Return On Assets
0.17
Return On Capital Employed
0.24
Net Income per EBT
0.78
EBT Per Ebit
1.08
Ebit per Revenue
0.15
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.34
Operating Profit Margin
0.15
Pretax Profit Margin
0.17
Net Profit Margin
0.13

Dividends

Dividend Yield
0
Dividend Yield %
0.29
Payout Ratio
0.08
Dividend Per Share
1.7

Operating Metrics

Operating Cashflow per Share
19.84
Free CashFlow per Share
16.75
Capex to Operating CashFlow
0.16
Capex to Revenue
0.02
Capex to Depreciation
0.75
Return on Invested Capital
0.21
Return on Tangible Assets
0.31
Days Sales Outstanding
28.91
Days Payables Outstanding
10.17
Days of Inventory on Hand
2.54
Receivables Turnover
12.63
Payables Turnover
35.87
Inventory Turnover
143.7
Capex per Share
3.09

Balance Sheet

Cash per Share
14,76
Book Value per Share
79,97
Tangible Book Value per Share
29.68
Shareholders Equity per Share
79.97
Interest Debt per Share
9.81
Debt to Equity
0.12
Debt to Assets
0.08
Net Debt to EBITDA
-0.18
Current Ratio
1.78
Tangible Asset Value
0,45 Bil.
Net Current Asset Value
-0,06 Bil.
Invested Capital
1296529000
Working Capital
0,20 Bil.
Intangibles to Total Assets
0.44
Average Receivables
0,18 Bil.
Average Payables
0,04 Bil.
Average Inventory
10723500
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Chemed Corporation Dividends
Year Dividends Growth
1985 2
1986 2 0%
1987 2 0%
1988 2 0%
1989 2 0%
1990 2 0%
1991 2 0%
1992 2 50%
1993 2 0%
1994 2 0%
1995 2 0%
1996 2 0%
1997 2 0%
1998 2 0%
1999 2 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 100%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 2 0%
2024 1 0%

Chemed Corporation Profile

About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CEO
Mr. Kevin J. McNamara
Employee
15.087
Address
255 East Fifth Street
Cincinnati, 45202-4726

Chemed Corporation Executives & BODs

Chemed Corporation Executives & BODs
# Name Age
1 Mr. Nathan J. McNamara
Vice President & Chief Strategy Officer
70
2 Mr. Brian C. Judkins
Vice President, Secretary & Chief Legal Officer
70
3 Sherri Warner
Director of Investor Relations
70
4 Mr. Kevin J. McNamara
Chief Executive Officer, President & Director
70
5 Mr. Thomas C. Hutton
Vice President & Director
70
6 Mr. Michael D. Witzeman CPA, MBA
Vice President, Controller, Principal Accounting Officer & Chief Financial Officer
70
7 Mr. Spencer S. Lee
Executive Vice President
70
8 Mr. Nicholas Michael Westfall
Executive Vice President
70
9 Ms. Lisa A. Reinhard
Vice President, Chief Administrative Officer & Secretary
70

Chemed Corporation Competitors